AvePoint announces pricing of 13.29 million shares for public offering, set to list on Singapore Exchange.
Quiver AI Summary
AvePoint, a leader in data security and governance, announced the pricing of a public offering of 13,290,360 shares of common stock at S$19.50 per share, with shares being offered by selling stockholders. This offering is part of AvePoint's plan to list its shares on the Singapore Exchange under the symbol "AVP," with trading expected to start on September 19, 2025. The underwriters have an option to purchase an additional 1,993,550 shares for over-allotments. Proceeds from the offering will not go to AvePoint, and several financial institutions are involved as joint coordinators and bookrunners. The company aims to create a market for its stock in Singapore, and all relevant documents have been filed with the SEC. The press release includes a caution regarding forward-looking statements and emphasizes that AvePoint does not guarantee its projections will be met.
Potential Positives
- AvePoint is set to list its shares on the Main Board of the Singapore Exchange, which could enhance its visibility and market presence in Asia.
- The public offering of 13,290,360 shares indicates strong interest from stockholders and could potentially increase stock liquidity.
- The Offering is aimed at creating a market for AvePoint’s common stock on the SGX-ST, which may attract new investors and broaden the shareholder base.
- The underwriters have an option for additional shares, allowing for flexibility in managing demand and supporting stock performance post-offering.
Potential Negatives
- The public offering may lead to shareholder dilution, as existing shareholders may see the value of their shares decrease due to the increased number of shares available in the market.
- AvePoint will not receive any proceeds from the offering, which raises concerns about the company's current cash flow situation and its funding for operations or growth initiatives.
- The reliance on selling stockholders to create a market for its shares on the SGX-ST could indicate a lack of confidence in the demand for their stock through direct public offerings.
FAQ
What is AvePoint's recent public offering?
AvePoint has announced a public offering of 13,290,360 shares of common stock at S$19.50 per share.
When will AvePoint's stock begin trading on SGX-ST?
AvePoint's stock is expected to begin trading on the SGX-ST on September 19, 2025, under the symbol "AVP."
Who are the underwriters for the offering?
The underwriters include Jefferies LLC, Morgan Stanley & Co. LLC, Oversea-Chinese Banking Corporation Limited, and UBS Securities LLC.
Will AvePoint receive proceeds from this offering?
No, AvePoint will not receive any proceeds from the public offering.
How can I obtain the prospectus for the offering?
The prospectus can be obtained from the underwriters via their respective contact details mentioned in the press release.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$AVPT Insider Trading Activity
$AVPT insiders have traded $AVPT stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $AVPT stock by insiders over the last 6 months:
- JEFF EPSTEIN sold 500,000 shares for an estimated $9,385,000
- BRIAN MICHAEL BROWN (Chief Legal Officer) has made 0 purchases and 6 sales selling 210,000 shares for an estimated $3,539,900.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AVPT Hedge Fund Activity
We have seen 123 institutional investors add shares of $AVPT stock to their portfolio, and 163 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. added 3,657,692 shares (+218.0%) to their portfolio in Q2 2025, for an estimated $70,630,032
- VANGUARD GROUP INC added 1,975,971 shares (+13.6%) to their portfolio in Q2 2025, for an estimated $38,156,000
- MILLENNIUM MANAGEMENT LLC removed 1,645,229 shares (-79.9%) from their portfolio in Q2 2025, for an estimated $31,769,371
- DRIEHAUS CAPITAL MANAGEMENT LLC added 1,525,405 shares (+135.6%) to their portfolio in Q2 2025, for an estimated $29,455,570
- UBS GROUP AG removed 1,072,434 shares (-81.4%) from their portfolio in Q2 2025, for an estimated $20,708,700
- FRANKLIN RESOURCES INC added 893,384 shares (+72.2%) to their portfolio in Q2 2025, for an estimated $17,251,245
- JENNISON ASSOCIATES LLC added 786,016 shares (+37.0%) to their portfolio in Q2 2025, for an estimated $15,177,968
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AVPT Analyst Ratings
Wall Street analysts have issued reports on $AVPT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 08/26/2025
- Scotiabank issued a "Sector Outperform" rating on 05/09/2025
To track analyst ratings and price targets for $AVPT, check out Quiver Quantitative's $AVPT forecast page.
$AVPT Price Targets
Multiple analysts have issued price targets for $AVPT recently. We have seen 6 analysts offer price targets for $AVPT in the last 6 months, with a median target of $20.5.
Here are some recent targets:
- An analyst from B. Riley Securities set a target price of $25.0 on 08/26/2025
- Fatima Boolani from Citigroup set a target price of $18.0 on 08/18/2025
- Joseph Gallo from Jefferies set a target price of $22.0 on 07/21/2025
- Gabriela Borges from Goldman Sachs set a target price of $17.0 on 05/12/2025
- Joe Vandrick from Scotiabank set a target price of $22.0 on 05/09/2025
Full Release
JERSEY CITY, N.J., Sept. 16, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced the pricing of an underwritten public offering (the “Offering”) of 13,290,360 shares of its common stock, par value $0.0001, with such shares of common stock being offered by the selling stockholders named in the prospectus (the “Selling Stockholders”), at a public offering price of S$19.50 per share, in connection with the previously announced plan to list its shares of common stock on the Main Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”).
AvePoint’s common stock is listed on Nasdaq under the symbol “AVPT.” AvePoint’s common stock is expected to begin trading on the SGX-ST at 9:00 a.m. (Singapore time) on September 19, 2025 under the symbol “AVP”, following the settlement of the Offering around 8:30 p.m. (Eastern time) on September 18, 2025. In addition, KEM Phoenix, LLC has granted the underwriters an option to purchase up to an additional 1,993,550 shares of common stock, exercisable within a 30-day period from the SGX-ST listing date, at the public offering price, solely to cover over-allotments in the Offering, if any.
The principal purpose of the Offering is to create a market for AvePoint’s common stock on the SGX-ST. AvePoint will not receive any proceeds from the Offering.
Jefferies LLC, Morgan Stanley & Co. LLC, Oversea-Chinese Banking Corporation Limited and UBS Securities LLC are acting as joint global coordinators and joint bookrunners for the Offering.
A registration statement on Form S-3 (Registration No. 333-290264) (including a base prospectus) has been filed with the SEC and became automatically effective on September 15, 2025. A preliminary prospectus supplement and accompanying prospectus relating to the Offering have been filed with the SEC and are available on the SEC’s website located at http://www.sec.gov . A final prospectus supplement reflecting the final terms of the Offering will be filed with the SEC. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the Offering may be obtained from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY, 10022, by telephone at 877-821-7388, or by email at [email protected]; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or by email at [email protected]; Oversea-Chinese Banking Corporation Limited, by telephone at +65 6530 1275; or UBS Securities LLC, Attention: Prospectus Department, 11 Madison Avenue, New York, New York 10010, by telephone at (888) 827-7275, or by email at [email protected].
This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer or an invitation to buy any securities of AvePoint, nor shall there be any offer or sale of the securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About AvePoint:
Beyond Secure. AvePoint is the global leader in data security, governance, and resilience, going beyond traditional solutions to ensure a robust data foundation and enable organizations everywhere to collaborate with confidence. Over 25,000 customers worldwide rely on the AvePoint Confidence Platform to prepare, secure, and optimize their critical data across Microsoft, Google, Salesforce, and other collaboration environments. AvePoint’s global channel partner program includes approximately 5,000 managed service providers, value-added resellers, and systems integrators, with our solutions available in more than 100 cloud marketplaces. To learn more, visit www.avepoint.com .
Forward-Looking Statements:
This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and other federal securities laws including statements regarding the future performance of and market opportunities for AvePoint. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: changes in the competitive and regulated industries in which AvePoint operates, variations in operating performance across competitors, changes in laws and regulations affecting AvePoint’s business and changes in AvePoint’s ability to implement business plans, forecasts, and ability to identify and realize additional opportunities, and the risk of downturns in the market and the technology industry. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of AvePoint’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Copies of these and other documents filed by AvePoint from time to time are available on the SEC's website, www.sec.gov . These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and AvePoint does not assume any obligation and does not intend to update or revise these forward-looking statements after the date of this release, whether as a result of new information, future events, or otherwise, except as required by law. AvePoint does not give any assurance that it will achieve its expectations. Unless the context otherwise indicates, references in this press release to the terms “AvePoint,” “the Company,” “we,” “our” and “us” refer to AvePoint, Inc. and its subsidiaries.
Disclosure Information:
AvePoint uses the https://www.avepoint.com/ir website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Investor Contact
AvePoint
Jamie Arestia
[email protected]
(551) 220-5654
Media Contact
AvePoint
Nicole Caci
[email protected]
(201) 201-8143